Hua Medicine
Shanghai
About Hua Medicine
Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $242.4M
- Funding stage: IPO
- Last round: Series E (Mar 2018)
- Ticker: hkg:2552
- Website: huamedicine.com
- Phone: +86 21 5886 9997
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hua-medicine-178721 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.